UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)BIRD, Jenny; BEHRENS, Judith; GREGERSEN, Henrik et al.British journal of haematology. 2009, Vol 147, Num 1, pp 22-42, issn 0007-1048, 21 p.Article

Mortality and causes of death in patients with monoclonal gammopathy of undetermined significanceGREGERSEN, Henrik; IBSEN, Jenna Salling; MELLEMKJOER, Lene et al.British journal of haematology. 2001, Vol 112, Num 2, pp 353-357, issn 0007-1048Article

The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significanceGREGERSEN, Henrik; MELLEMKJAER, Lene; IBSEN, Jenna Salling et al.Haematologica (Roma). 2001, Vol 86, Num 11, pp 1172-1179, issn 0390-6078Article

Fracture risk in patients with monoclonal gammopathy of undetermined significanceGREGERSEN, Henrik; JENSEN, Paw; GISLUM, Mette et al.British journal of haematology. 2006, Vol 135, Num 1, pp 62-67, issn 0007-1048, 6 p.Article

Multiple myeloma following an episode of community-acquired pneumococcal bacteraemia or meningitisGREGERSEN, Henrik; PEDERSEN, Gitte; SVENDSEN, Nicolaj et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2001, Vol 109, Num 11, pp 797-800, issn 0903-4641Article

A polymorphism in NFKB1 is associated with improved effect of interferon-α maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell supportVANGSTED, Annette J; KLAUSEN, Tobias W; GIMSING, Peter et al.Haematologica (Roma). 2009, Vol 94, Num 9, pp 1274-1281, issn 0390-6078, 8 p.Article

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtypeSMEDBY, Karin Ekström; HJALGRIM, Henrik; ADAMI, Hans-Olov et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 1, pp 51-60, issn 0027-8874, 10 p.Article